Biomedicines Webinar | Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
the chair
5th Biomedicines Webinar
Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
Dear colleagues,
We are pleased to announce the upcoming webinar “Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches”, which will be held on Tuesday, February 7, 2023, at 2:00-3:15 pm CET.
Renal cell carcinoma is a complex disease comprised of a variety of histological subtypes. This webinar focuses on recent advances on clinicopathological, physiological, and molecular approaches to the diagnosis, classification, and novel multidisciplinary treatment of renal cell carcinoma.
The recently published fifth edition of the WHO classification for renal cell carcinoma contains significant revisions. In this webinar, two pathologists will present overviews of the latest advances in the pathology of renal cell carcinomas with papillary features and oncocytic and chromophobe renal tumors, including emerging/provisional entities and those relevant molecular aspects. A Urologist will present recent medical therapy for advanced or metastatic renal cell carcinoma. The speakers will each speak for approximately 15 minutes, and then we will open it up to questions from the audience and discussion. Please join us live for this webinar and contribute to the discussion.
Dr. Silvio Maringhini
Dr. Riuko Ohashi
Date: 7 February 2023
Time: 2:00 pm CET | 8:00 am EST | 9:00 pm CST Asia
Webinar ID: 863 9563 8016
Webinar Secretariat: biomedicines.webinar@mdpi.com
Meet Our Speakers
Dr. Silvio Maringhini
Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, 90127 Palermo, Italy;
Dr. Silvio Maringhini received his Medical Doctor from University of Palermo in 1975; He acted as Director, Pediatric Nephrology Unit, Children’s Hospital, Palermo, Italy from 1995 to 2017. 2018-present, he is Consultant Nephrologist, ISMETT, Palermo. Memberships: International Association of Pediatric Nephrology, European Society of Paediatric Nephrology (President of the 2006 Meeting, Chair Working Group “CAKUT, Urinary Tract Infections, Bladder Disorders), Società Italiana di Nefrologia, Società Italiana di Nefrologia Pediatrica (Past President).
Dr. Riuko Ohashi
Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Japan;
Dr. Riuko Ohashi is an associate professor of pathology at the Niigata University, Japan. She received her MD from the Hamamatsu University School of Medicine in 2001, her doctorate degree from the Niigata University in 2015, and had postdoctoral experience at the Department of Pathology and Molecular Pathology, University Hospital Zurich (Switzerland). She has coauthored several chapters on renal cell carcinoma in the fifth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO "Blue Book"), published in 2022. Her research interests include translational molecular pathology and developing a clinicopathological prognostic stratification system for renal cancer.
On Tuesday, 7 February 2023, MDPI and the Journal Biomedicines organized the 5th Webinar of the Biomedicines series, entitled “Biomedicines Webinar | Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches”. This online seminar was chaired by Dr. Silvio Maringhini, from Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy, and by Dr. Riuko Ohashi, from Niigata University, Japan.
The first speaker to kick off the webinar was Dr. João Lobo, who gave a talk on the different morphologies of renal cell tumors and their papillary features. The webinar chair Dr. Riuko Ohashi followed with her presentation on oncocytic and chromophobe renal tumors. Finally, Prof. Dr. Dr. Koji Iinuma addressed the current medical therapies for advanced or metastatic renal cell carcinoma. Speaker presentations were followed by a Q&A session moderated by the chairs.
The webinar was offered via Zoom and required registration to attend. The full recording can be found below. To stay updated on the next Biomedicines webinars, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
Renal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches 2.0
Guest Editors: Dr. Silvio Maringhini and Dr. Riuko Ohashi
Deadline for manuscript submissions: 15 March 2023